Ondokuz Mayıs University   Report issue

Academic/Hospital Phase 1 Phase 4
Founded: Samsun Turkey (1975)

Organization Overview

First Clinical Trial
2007
NCT01205984
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cengiz KAYA | Martyr Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital | Ondokuz Mayis Universitesi | Ondokuz Mayıs University | Ondokuz Mayıs University, School of Dentistry, Department of Periodontology | Ondokuz Mayis University, School of Medicine, Department of Anesthesiology | Sümeyye BAL

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cognitive Dysfunction (Phase 4)

Obesity, Morbid (Phase 4)

Osteoporosis (Phase 4)

Osteoporosis, Postmenopausal (Phase 4)

Periodontitis (Phase 4)

Sinusitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 15